Novel Selective and Partial Agonists of 5-HT3 Receptors. Part 1. Synthesis and Biological Evaluation of Piperazinopyrrolothienopyrazines
摘要:
A series of piperazinopyrrolo[1,2-a]thieno[3,2-e]- and -[2,3-e]pyrazine derivatives were prepared and evaluated in order to determine the necessary requirements for high affinity on the 5-HT3 receptors and high selectivity versus other 5-HT receptor subtypes. Various substitutions on the piperazine and the thiophene ring of the pyrrolothienopyrazine moieties were systematically explored as well as replacement of the piperazine by other cyclic amines. The best compounds are in the nanomolar range of affinity for 5-HT3 receptors with high to very high selectivity (up to 10 000 for 14b). These high-affinity compounds have in common a benzyl- or allylpiperazine substituent with no substitutions on the thiophene ring. Five of these compounds (1a, 4b, 13a,b, and 14b) have been evaluated on the Von Bezold-Jarisch reflex and were characterized as partial agonists. One of them, 13a, has shown in vivo at very low dose a potent anxiolytic-like activity in the light/dark test.
Composés pyrrolothiénopyraziniques comme antagonistes des récepteurs 5-HT3
申请人:ADIR ET COMPAGNIE
公开号:EP0573360A1
公开(公告)日:1993-12-08
L'invention concerne les composés de formule générale (I) :
dans laquelle R₁, R₂, R₃, et A sont tels que définis dans la description, leurs isomères optiques,
et leurs sels d'addition à un acide ou une base pharmaceutiquement acceptable.
Médicaments.
本发明涉及通式 (I) 的化合物:
其中 R₁、R₂、R₃ 和 A 如描述中所定义,以及它们的光学异构体、
及其与药学上可接受的酸或碱的加成盐。
药物。
Synthesis of [11C]-S21007 a novel 5HT3 partial agonist as a potential tracer for PET studies
作者:S. Guillouet、L. Barre、F. Gourand、M. C. Lasne、S. Rault
A novel selective and partial agonist S21007 (IC50 = 1nM) for 5HT(3) receptor studies in positron emission tomography, has been labelled with [ C-11]benzyl iodide in 40-50% radiochemical yield and 200-700mCi/mu mol in 60 min synthesis time.
A series of piperazinopyrrolo[1,2-a]thieno[3,2-e]- and -[2,3-e]pyrazine derivatives were prepared and evaluated in order to determine the necessary requirements for high affinity on the 5-HT3 receptors and high selectivity versus other 5-HT receptor subtypes. Various substitutions on the piperazine and the thiophene ring of the pyrrolothienopyrazine moieties were systematically explored as well as replacement of the piperazine by other cyclic amines. The best compounds are in the nanomolar range of affinity for 5-HT3 receptors with high to very high selectivity (up to 10 000 for 14b). These high-affinity compounds have in common a benzyl- or allylpiperazine substituent with no substitutions on the thiophene ring. Five of these compounds (1a, 4b, 13a,b, and 14b) have been evaluated on the Von Bezold-Jarisch reflex and were characterized as partial agonists. One of them, 13a, has shown in vivo at very low dose a potent anxiolytic-like activity in the light/dark test.
Synthesis of aminopyrrolo[1,2-a]thieno[3,2-e]pyrazine derivatives as serotoninergic 5-HT7 ligands
A series of piperazinopyrrolo[1,2-a]thieno[3,2-e]pyrazinederivatives were prepared and evaluated to determine their affinity for the 5-HT7 receptor. Various substitutions on piperazine were explored as well as replacement of the piperazine by other amines.